A prospective, open, single-arm, multicenter phase II clinical trial to evaluate the progression free survival and safety in patients with advanced colorectal carcinoma treated with AMT2003.
Phase of Trial: Phase II/III
Latest Information Update: 19 Mar 2013
At a glance
- Drugs AMT 2003 (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
- 30 Jan 2007 New trial record.